Table 2 Change in medical treatment from 6 months before to 6 months after coronary angiography in diabetes patients without coronary artery disease and with > 6 months of follow-up (n = 5661)

From: Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study

  Beforea Afterb New usersc Former usersd Net changee (±)
Aspirin 55.1% 53.9% 11.9% 13.0% − 1.1%
Statins 66.6% 70.0% 9.4% 6.0% + 3.4%
Adenosine diphosphate-inhibitors 3.3% 4.6% 2.5% 1.2% + 1.3%
Vitamin-K antagonist 13.0% 19.3% 7.5% 1.2% + 6.3%
Direct oral anti-coagulants 2.3% 3.7% 1.7% 0.4% + 1.3%
Beta-blockers 46.5% 52.6% 13.0% 6.9% + 6.1%
Angiotensin converting enzyme-inhibitors 41.6% 43.5% 7.8% 5.9% + 1.9%
Angiotensin-II receptor blockers 28.4% 29.2% 4.2% 3.4% + 0.8%
Thiazide 19.4% 18.1% 4.5% 5.8% − 1.3%
Calcium-blockers 32.0% 33.4% 7.7% 6.3% + 1.4%
Insulin 27.0% 29.9% 3.8% 0.9% + 2.9%
Non-insulin diabetes medication 61.6% 62.2% 4.6% 4.0% + 0.6%
  1. aBefore: redeemed ≥ 1 prescription within 6 months before angiography
  2. bAfter: redeemed ≥ 1 prescription within 6 months after angiography
  3. cNew user: redeemed ≥ 1 prescription within 6 months after angiography, but not 6 months before
  4. dFormer user: redeemed ≥ 1 prescription within 6 months before angiography, but not 6 months after
  5. eNet change: overall change in prescriptions from before to after angiography